1 or antagonists have been used effectively as potassium-sparing and renal-function-protective diuretic

2 While blockade of ASIC1 through amiloride, a potassium sparing diuretic that is currently licensed fo

3                                     Only non-potassium-sparing diuretic use was independently associa

4  Conclusions-In SOLVD, baseline use of a non-potassium-sparing diuretic was associated with an increa

5  arrhythmic death, whereas baseline use of a potassium-sparing diuretic was not.

6                                     Use of a potassium-sparing diuretic, alone or in combination with

7 sessed whether addition or substitution of a potassium-sparing diuretic, amiloride, to treatment with

8 diuretic, alone or in combination with a non-potassium-sparing diuretic, was not independently associ

9           We sought to determine whether non-potassium-sparing diuretics (PSDs) in the absence of a P

10 th in hypertensive patients treated with non-potassium-sparing diuretics is reported.

11 losing tubulopathy, are usually treated with potassium-sparing diuretics or nonsteroidal anti-inflamm